Problems with serum IgM as a screening test for congenital infection. 1994

B E Mahon, and E G Yamada, and T B Newman
Pediatric Residency Program, School of Medicine, University of California, San Francisco.

The purpose of this study was to determine the usefulness of the total serum IgM level as a screening test for congenital infection in asymptomatic or mildly symptomatic infants. A retrospective medical record review was performed on 168 infants in whom the serum IgM was measured as a screen for congenital infection. The indications for testing, the yield of testing, and the adequacy of follow-up of abnormal values were examined. Only one infant was diagnosed with a congenital infection which was not specifically suspected prior to screening; this was a case of congenital cytomegalovirus (CMV). Inappropriate screening was frequently performed in infants in whom indications for specific evaluation were present. Appropriate follow-up testing was performed in only 30% (seven of 23) of the infants with elevated serum IgM who received their pediatric care at our institution. Because of the low yield (< 1%) and lack of follow-up shown in this study, as well as poor sensitivity, serum IgM was not a useful screening test for congenital infection in our institution.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

B E Mahon, and E G Yamada, and T B Newman
October 1984, Deutsche medizinische Wochenschrift (1946),
B E Mahon, and E G Yamada, and T B Newman
December 1969, The Journal of pediatrics,
B E Mahon, and E G Yamada, and T B Newman
July 1996, Journal of clinical microbiology,
B E Mahon, and E G Yamada, and T B Newman
August 1998, Early human development,
B E Mahon, and E G Yamada, and T B Newman
November 1972, Klinische Padiatrie,
B E Mahon, and E G Yamada, and T B Newman
December 1995, Journal of clinical microbiology,
B E Mahon, and E G Yamada, and T B Newman
January 1981, The Journal of pediatrics,
B E Mahon, and E G Yamada, and T B Newman
January 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
B E Mahon, and E G Yamada, and T B Newman
July 1982, Archives of disease in childhood,
B E Mahon, and E G Yamada, and T B Newman
January 2000, Diabetes technology & therapeutics,
Copied contents to your clipboard!